Inner Mongolia Furui Medical Science Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000KG1
CNY
65.84
-0.49 (-0.74%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
387.63
383.01
330.40
366.89
337.23
319.82
320.70
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
387.63
383.01
330.40
366.89
337.23
319.82
320.70
Raw Material Cost
95.91
117.64
94.71
140.20
99.31
88.61
87.34
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.79
0.82
0.65
0.90
0.62
0.66
0.59
Selling and Distribution Expenses
150.79
162.46
148.13
116.12
154.86
139.72
128.72
Other Expenses
3.04
2.28
1.74
2.57
2.20
2.41
2.48
Total Expenditure (Excl Depreciation)
277.93
303.70
260.83
282.97
276.80
253.10
241.50
Operating Profit (PBDIT) excl Other Income
109.7
79.3
69.6
83.9
60.4
66.7
79.2
Other Income
1.28
-14.04
-6.59
4.37
5.23
5.10
7.76
Operating Profit (PBDIT)
110.56
86.20
86.68
102.94
89.57
91.65
110.47
Interest
0.79
0.82
0.65
0.90
0.62
0.66
0.59
Exceptional Items
1.22
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
291.72
265.37
235.69
226.69
237.92
231.21
233.37
Depreciation
0.00
25.64
25.64
24.05
24.05
23.51
23.51
Profit Before Tax
110.99
59.74
60.40
77.99
64.91
67.49
86.38
Tax
25.37
18.01
18.44
22.94
16.45
17.47
17.81
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
59.95
23.30
28.64
11.28
26.64
32.64
42.72
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
59.95
23.30
28.64
11.28
26.64
32.64
42.72
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
24.09
12.98
13.04
25.44
20.77
13.71
22.68
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
84.04
36.28
41.68
36.73
47.40
46.35
65.40
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,905.44
1,824.94
1,781.97
1,747.68
1,602.84
1,586.86
1,566.67
Earnings per share (EPS)
0.23
0.09
0.11
0.04
0.1
0.12
0.16
Diluted Earnings per share
0.23
0.09
0.11
0.04
0.1
0.12
0.16
Operating Profit Margin (Excl OI)
28.19%
19.48%
20.47%
20.31%
17.88%
19.71%
24.7%
Gross Profit Margin
28.63%
22.29%
26.04%
27.81%
26.38%
28.45%
34.26%
PAT Margin
15.47%
6.08%
8.67%
3.08%
7.9%
10.21%
13.32%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2025 is 14.95% vs 19.36% in Sep 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2025 is 77.22% vs 8.72% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is 29.66% vs 15.01% in Sep 2024

stock-summary

Interest

YoY Growth in quarter ended Sep 2025 is 33.33% vs 20.00% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Compare Quarterly Results Of Inner Mongolia Furui Medical Science Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
387.63
0
387.63
Other Operating Income
0.00
0.00
0.00
Total Operating income
387.63
0
387.63
Raw Material Cost
95.91
0
95.91
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.79
0
0.79
Selling and Distribution Expenses
150.79
0
150.79
Other Expenses
3.04
0.00
3.04
Total Expenditure (Excl Depreciation)
277.93
0
277.93
Operating Profit (PBDIT) excl Other Income
109.70
0.00
109.70
Other Income
1.28
0
1.28
Operating Profit (PBDIT)
110.56
0
110.56
Interest
0.79
0
0.79
Exceptional Items
1.22
0
1.22
Gross Profit (PBDT)
291.72
0
291.72
Depreciation
0.00
0
0.00
Profit Before Tax
110.99
0
110.99
Tax
25.37
0
25.37
Provisions and contingencies
0
0
0.00
Profit After Tax
59.95
0
59.95
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
59.95
0
59.95
Share in Profit of Associates
0
0
0.00
Minority Interest
24.09
0
24.09
Other related items
0.00
0.00
0.00
Consolidated Net Profit
84.04
0
84.04
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,905.44
0
1,905.44
Earnings per share (EPS)
0.23
0
0.23
Diluted Earnings per share
0.23
0
0.23
Operating Profit Margin (Excl OI)
28.19%
0%
0.00
28.19%
Gross Profit Margin
28.63%
0%
0.00
28.63%
PAT Margin
15.47%
0%
0.00
15.47%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 38.76 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 1.20% vs 15.92% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 14.95% vs 19.36% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 8.40 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 131.40% vs -12.95% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 77.22% vs 8.72% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.93 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 9.08% vs 7.40% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 29.66% vs 15.01% in Sep 2024

Quarterly - Interest
Interest 0.08 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 0.00% vs 33.33% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 33.33% vs 20.00% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 28.19%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024